As Deputy Commissioner for Policy, Legislation, and International Affairs, Anna Abram played a critical role in overseeing the development and implementation of key policy initiatives and provided strategic policy direction to advance FDA’s mission and vision of protecting and promoting public health.
Prior to being appointed to this senior leadership position at the FDA, Ms. Abram served in the Office of the Secretary at the Department of Health and Human Services (HHS).
Ms. Abram is a respected FDA policy thought leader with more than fifteen years of health care policy experience, including more than a decade of working on health care policy in the United States Senate. She served as the long-time Health Policy Director and Senior Advisor to Senator Richard Burr at the Senate Health, Education, Labor and Pensions (HELP) Committee. In this role, she was actively involved in a range of health care issues under both the Senate HELP and Finance Committees. Her tenure at the Senate HELP Committee was particularly distinguished by her contributions to advancing bipartisan FDA and medical and public health preparedness and response legislation, including securing multiple patient-centered drug and device provisions in the Food and Drug Administration Safety and Innovation Act and 21st Century Cures laws.
Over the years, Ms. Abram has played key roles in advancing legislation to support innovation on behalf of patients and strengthen our nation’s public health. She spearheaded the bipartisan negotiation and enactment of the most significant security enhancements to our nation’s pharmaceutical supply chain in the past 25 years through the Drug Quality and Security Act. She also was instrumental in strengthening our nation’s medical countermeasure work and medical and public health preparedness and response programs through the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013.
Ms. Abram was previously appointed by President George W. Bush to serve as an Associate Director at the Domestic Policy Council at The White House. In this role, Ms. Abram coordinated the development and implementation of a range of health care policy issues, including food, drug and public health policy. She coordinated the White House-led, interagency policy process to reauthorize the President’s Emergency Plan for AIDS Relief (PEPFAR) in 2008.
Ms. Abram graduated magna cum laude from the University of Pennsylvania.